Attached files
| file | filename |
|---|---|
| EX-31.1 - EX-31.1 - ENANTA PHARMACEUTICALS INC | d21127dex311.htm |
| EX-31.2 - EX-31.2 - ENANTA PHARMACEUTICALS INC | d21127dex312.htm |
| EX-21.1 - EX-21.1 - ENANTA PHARMACEUTICALS INC | d21127dex211.htm |
| 10-K - 10-K - ENANTA PHARMACEUTICALS INC | d21127d10k.htm |
| EX-32.1 - EX-32.1 - ENANTA PHARMACEUTICALS INC | d21127dex321.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-189217, 333-192935 and 333-202257) of Enanta Pharmaceuticals, Inc. of our report dated December 11, 2015 relating to the financial statements, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
December 11, 2015